Shandong Xinhua Pharmaceutical (000756.SZ) obtained the registration certificate for Fumarate Bisoprolol Tablets.
Xinhua Pharmaceutical (000756.SZ) announced that the company has received approval from the National Medical Products Administration for the issuance of Fumaric Acid Bisoprolol...
Shandong Xinhua Pharmaceutical (000756.SZ) announced that the company has received the approved and issued Drug Registration Certificate for metoprolol succinate tablets from the National Medical Products Administration. The announcement states that metoprolol succinate tablets are indicated for hypertension, coronary heart disease (angina), and chronic stable heart failure with reduced left ventricular ejection fraction (35%). When using this product, it is necessary to follow medical advice and receive treatment with ACE inhibitors, diuretics, and selective use of cardiac glycosides.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
